Acute Coronary Syndrome in Type 2 Diabetes: Clinical Presentation, Risk Factor Burden, and Gender Disparities in an Iraqi Cohort

Authors

  • Mohammed Majeed Hameed Al-taee, M.B.Ch.B., C.A.B.M., Ibn Sena Teaching Hospital, Nineveh, Iraq
  • Mohammed Abd Alfattah Mohammed Albadranii M.B.Ch.B., C.A.B.M., Ibn Sena Teaching Hospital, Nineveh, Iraq

Keywords:

Acute Coronary Syndrome, Type 2 Diabetes

Abstract

Objective: To characterize the clinical presentation of acute coronary syndrome (ACS) in Iraqi patients with type 2 diabetes (T2DM) and evaluate gender-specific risk factor profiles.

Methods: A hospital-based case series of 105 T2DM patients admitted with ACS to Ibn Sina Teaching Hospital, Mosul (between April 2023–February 2024). Data included demographics, risk factors, ECG, echocardiography, and lipid profiles. Patients were categorized into ST-segment elevation myocardial infarction (STEMI) or non-ST-segment elevation MI/unstable angina (NSTEMI/UA).
Results: STEMI predominated (61.0%, n=64). Females exhibited higher rates of hypertension (63.6% vs. 14.8%), dyslipidemia (86.4% vs. 42.6%), and obesity (59.1% vs. 27.9%) (p<0.001). Heart failure was more frequent in NSTEMI/UA (43.9% vs. 23.1%, p=0.019). Over 50% presented without prior ischemic heart disease.
Conclusions: Iraqi T2DM patients with ACS frequently present with STEMI and extensive ischemia, particularly women with clustered metabolic risks. Gender-tailored prevention and regional screening programs are urgently needed.

Downloads

Download data is not yet available.

References

Sun H, Saeedi P, Karuranga S, et al. IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res ClinPract. 2022;183:109119.

Low Wang CC, Hess CN, Hiatt WR, Goldfine AB. Clinical update: Cardiovascular disease in diabetes mellitus: atherosclerotic cardiovascular disease and heart failure in type 2 diabetes mellitus - mechanisms, management, and clinical considerations. Circulation. 2016;133(24):2459-2502.

Einarson TR, Acs A, Ludwig C, Panton UH. Prevalence of cardiovascular disease in type 2 diabetes: a systematic literature review of scientific evidence from across the world in 2007-2017. CardiovascDiabetol. 2018;17(1):83.

Mansour AA, Al-Maliky AA, Kasem B, Jabar A, Mosbeh KA. Prevalence of diagnosed and undiagnosed diabetes mellitus in adults aged 19 years and older in Basrah, Iraq. Diabetes MetabSyndrObes. 2020;13:2353-2359.

Al-Zakwani I, Al-Mahruqi F, Al-Rasadi K, et al. Sex disparity in cardiovascular risk factors among type 2 diabetics in Middle Eastern countries: a systematic review and meta-analysis. PLoS One. 2021;16(3).

Alhabib KF, Al-Shehri AM, Alfaleh H, et al. Prospective cohort of patients with acute coronary syndrome in a tertiary care center in Saudi Arabia. Saudi Med J. 2022;43(7):686-695.

Ahmed AM, Hassan KA, Hassanein M, et al. Cardiovascular risk factors burden in Saudi Arabia: the Africa Middle East Cardiovascular Epidemiological (ACE) study. J Saudi Heart Assoc. 2017;29(4):235-243.

Peters SAE, Woodward M. Sex differences in the burden and complications of diabetes. CurrDiab Rep. 2018;18(6):33.

Gulati M, Levy PD, Mukherjee D, et al. 2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR guideline for the evaluation and diagnosis of chest pain: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2021;144(22).

Bornfeldt KE, Tabas I. Insulin resistance, hyperglycemia, and atherosclerosis. Cell Metab. 2011;14(5):575-585.

Rosenson RS, Davidson MH, Hirsh BJ, Kathiresan S, Gaudet D. Genetics and causality of triglyceride-rich lipoproteins in atherosclerotic cardiovascular disease. J Am CollCardiol. 2014;64(23):2525-2540.

Marso SP, Daniels GH, Brown-Frandsen K, et al. Liraglutide and cardiovascular outcomes in type 2 diabetes. N Engl J Med. 2016;375(4):311-322.

American Diabetes Association Professional Practice Committee. 2. Classification and diagnosis of diabetes: Standards of medical care in diabetes-2023. Diabetes Care. 2023;46(Suppl 1).

Collet JP, Thiele H, Barbato E, et al. 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J. 2021;42(14):1289-1367.

Arora S, Stouffer GA, Kucharska-Newton AM, et al. Twenty year trends and sex differences in young adults hospitalized with acute myocardial infarction. Circulation. 2019;139(8):1047-1056.

Al-Lawati JA, Al-Zakwani I, Sulaiman K, et al. Prevalence, predictors, and outcomes of patient delay in patients with acute coronary syndrome from the Middle East GULF registry. Angiology. 2021;72(10):949-956.

Peters SAE, Huxley RR, Woodward M. Diabetes as risk factor for incident coronary heart disease in women compared with men: a systematic review and meta-analysis of 64 cohorts including 858,507 individuals and 28,203 coronary events. Diabetologia. 2014;57(8):1542-1551.

Mauvais-Jarvis F, Manson JE, Stevenson JC, Fonseca VA. Menopausal hormone therapy and type 2 diabetes prevention: evidence, mechanisms, and clinical implications. Endocr Rev. 2017;38(3):173-188.

Ministry of Health and Ministry of Planning - Iraq. Iraq National Non-Communicable Disease Risk Factors Survey (STEPS) 2015. Baghdad: Ministry of Health; 2016.

Al-Mawali A, Al-Rasadi K, Elshafie O, et al. Adherence to the American Diabetes Association standards of care among patients with type 2 diabetes in primary care in Oman. Int J Prev Med. 2022;13:24.

Seferović PM, Petrie MC, Filippatos GS, et al. Type 2 diabetes mellitus and heart failure: a position statement from the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail. 2018;20(5):853-872.

Aljefree N, Ahmed F. Prevalence of cardiovascular disease and associated risk factors among adult population in the Gulf region: a systematic review. Adv Public Health. 2015;2015:235101.

Ismail MD, Jalalonmuhali M, Azhari Z, et al. Prescribing pattern of antidiabetic agents among type 2 diabetes patients with chronic kidney disease in Malaysia: a cross-sectional study. Int J Environ Res Public Health. 2021;18(5):2392.

Alaboud AF, Tourkmani AM, Alharbi TJ, et al. Microvascular and macrovascular complications of type 2 diabetic patients in Military Hospital in Southern Region, Kingdom of Saudi Arabia. J Family Med Prim Care. 2019;8(1):150-156.

Al-Rifai RH, Majeed M, Qambar MA, et al. Type 2 diabetes and pre-diabetes mellitus: a systematic review and meta-analysis of prevalence studies in women of childbearing age in the Middle East and North Africa, 2000-2018. Syst Rev. 2019;8(1):268.

Shah AD, Langenberg C, Rapsomaniki E, et al. Type 2 diabetes and incidence of cardiovascular diseases: a cohort study in 1•9 million people. Lancet Diabetes Endocrinol. 2015;3(2):105-113.

Suleiman KH, Suleiman AK, Kheirallah K, et al. Barriers to implementing cardiovascular risk reduction guidelines in patients with diabetes mellitus in Jordan. Int J ClinPract. 2021;75(6).

Al-Zakwani I, Al-Mahmeed W, Arafah M, et al. Control of risk factors for cardiovascular disease among multinational patient population in the Arabian Gulf. Curr Med Res Opin. 2018;34(4):603-609.

Al Slail FY, Abid O, Assiri AM, Memish ZA, Ali MK. Cardiovascular risk profiles of adults with type-2 diabetes treated at urban hospitals in Riyadh, Saudi Arabia. J Epidemiol Glob Health. 2016;6(1):29-36.

Aldiab A, Shubair MM, Al-Zahrani JM, et al. Prevalence of hypertension and prehypertension and its associated cardioembolic risk factors; a population based cross-sectional study in Alkharj, Saudi Arabia. BMC Public Health. 2018;18(1):1327.

Downloads

Published

2025-05-01

How to Cite

Mohammed Majeed Hameed Al-taee, & Mohammed Abd Alfattah Mohammed Albadranii. (2025). Acute Coronary Syndrome in Type 2 Diabetes: Clinical Presentation, Risk Factor Burden, and Gender Disparities in an Iraqi Cohort. Current Clinical and Medical Education, 3(5), 1–6. Retrieved from https://www.visionpublisher.info/index.php/ccme/article/view/237

Issue

Section

Articles